Clinical Trials in Florida

Showing 10561-10580 of 10,975 trials

Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD

NCT00509548

Wet age-related macular degeneration (AMD) is caused by the formation and growth of abnormal blood vessels (angiogenesis) in the retina. The new blood vessels have fragile walls and can leak fluid into the retina. The build-up of fluid (edema) under the macula can distort vision or cause vision loss. TG100801 is a topical (eye drop) therapy that has been shown to inhibit ocular angiogenesis, vascular leak, and inflammation in laboratory studies. The primary purpose of this pilot study is to evaluate the ability of topical administration of TG100801 to reduce the amount of fluid in the retina in patients with AMD following 30 days of treatment. An additional objective is to evaluate the safety of TG100801 in patients with AMD.

Macular DegenerationChoroidal Neovascularization

TargeGen7 participantsStarted Jul 2007

Tucson, Arizona, United States • Beverly Hills, California, United States • Winter Haven, Florida, United States +5 more locations

COMPLETEDPhase 349 miles

Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)

NCT00365300

To assess the efficacy of pantoprazole for the treatment of infants with symptomatic Gastroesophageal Reflux Disease (GERD).

Gastroesophageal Reflux

Wyeth is now a wholly owned subsidiary of Pfizer129 participantsStarted Sep 2006

Mobile, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +35 more locations

Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD

Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)

Find Trials by Condition in Florida

Diabetes Control and Complications Trial (DCCT)

Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Efficacy of Digital Noise Reduction Strategies: A Hearing Aid Trial

A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis

A Trial of Skin Care Protocols for Facial Resurfacing

Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region

Study of XL999 in Patients With Previously Treated Ovarian Cancer

Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)

Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD

Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus

Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)